OTC: SHPMF - Shanghai Pharmaceuticals Holding Co., Ltd

半年間の収益性: -6.47%
配当利回り: +4.36%
セクタ: Healthcare

プロモーションスケジュール Shanghai Pharmaceuticals Holding Co., Ltd

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs.

さらに詳しく
The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores, and online drug business. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 4.12
Дивиденд ао 0.0676
Сайт https://www.sphchina.com
Цена ао 1.56
1日あたりの価格変動: +0% (1.562)
週ごとの価格変動: +0% (1.562)
月ごとの料金変更: +31.26% (1.19)
3ヶ月間の価格変動: -4.76% (1.64)
半年間の価格変動: -6.47% (1.67)
年間の価格変動: +5.19% (1.485)
3年間の価格推移: -10.74% (1.75)
年初からの価格変動: -4.76% (1.64)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0.1331 10
P/BV 0.0607 10
P/E 9.19 9
EV/EBITDA 12.31 7
合計: 7.38

効率

名前 意味 学年
ROA, % 0.2504 1
ROE, % 0.7745 1
合計: 0.8333

配当金

名前 意味 学年
Div yield, % 4.36 10
DSI 0.7143 7.14
合計: 6.7

義務

名前 意味 学年
Debt/EBITDA 26.99 0
合計: 3.2

成長の衝動

名前 意味 学年
収益性 Revenue, % -80.29 0
収益性 Ebitda, % -83.84 0
収益性 EPS, % -90.01 0
合計: 0
さらに詳しく

さらに詳しく

機関 音量 共有, %
Vanguard International Stock Index-Emerging Markets Stk 12146926 1.32
Vanguard International Stock Index-Total Intl Stock Indx 11883576 1.29
iShares Core MSCI Emerging Markets ETF 7102300 0.77
Brandes Emerging Markets Value Fund 5203000 0.57
DFA Emerging Markets Core Equity Portfolio 4172100 0.45
iShares MSCI Emerging Markets Minimum Volatility Factor ETF 3566400 0.39
DFA Investment Dimensions-DFA Emerging Mkts Value 3299900 0.36
iShares ESG Aware MSCI EM ETF 3014100 0.33
iShares MSCI China ETF 2093800 0.23
iShares MSCI Emerging Markets ETF 1923800 0.21



スーパーバイザー 役職 支払い 生年
Mr. Bo Shen President, CFO, Head of the Accounting Department & Executive Director 804.26k 1973 (52 年)
Mr. Yongzhong Li VP & Executive Director 904.39k 1970 (55 年)
Mr. Tao Zhong VP, Board Secretary & Joint Company Secretary N/A 1972 (53 年)
Mr. Dongming Li Vice President N/A 1969 (56 年)
Ms. Shuai Shao Vice President N/A 1988 (37 年)
Dr. Shunjiang Yu Chief Medical Officer N/A
Mr. Ming Dong Executive Director N/A 1976 (49 年)
Ying Ke Director & General Manager of R&D Management Center N/A
Mr. Qiuhua Yang Executive Chairman N/A 1972 (53 年)
Ms. Pui Kiu Wong Joint Company Secretary N/A

住所: China, Shanghai, Shanghai Pharmaceutical Building - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.sphchina.com